Literature DB >> 25126229

Schizophrenia: current concepts and approaches to patient care.

Peter F Buckley1, Adriana Foster2.   

Abstract

Schizophrenia is the most serious of all mental conditions. It is typically a long-lasting condition characterized by repeated relapses and by marked functional impairment. Genetic and environmental factors are important. Exactly which factors and how these combine to cause schizophrenia is still unclear. Antipsychotic medications form the bedrock for treatment. These drugs are effective, but not entirely so, and are associated with negative side effects. Individual differences among the available medications suggest that trials with a different medication may be appropriate when one agent fails or is not appropriate for the specific patient. Monitoring for side effects is important to ensure efficacy and compliance. Often, patients choose to stop taking their medications for a variety of reasons, which invariably will lead most patients to a relapse of illness. Beyond medications, patients need considerable support and specialized services. Families are a key resource. The recent focus on personal determination has led to recovery-based services, including the incorporation of peer support into patient care.

Entities:  

Year:  2008        PMID: 25126229      PMCID: PMC4106628     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN: 1942-2962


  29 in total

Review 1.  Practice guideline for the treatment of patients with schizophrenia, second edition.

Authors:  Anthony F Lehman; Jeffrey A Lieberman; Lisa B Dixon; Thomas H McGlashan; Alexander L Miller; Diana O Perkins; Julie Kreyenbuhl
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

Review 2.  Structural and functional magnetic resonance imaging in psychiatric disorders.

Authors:  Godfrey D Pearlson; Vince Calhoun
Journal:  Can J Psychiatry       Date:  2007-03       Impact factor: 4.356

Review 3.  Factors that influence treatment success in schizophrenia.

Authors:  Peter F Buckley
Journal:  J Clin Psychiatry       Date:  2008       Impact factor: 4.384

Review 4.  A critical review of research on psychosocial treatment of schizophrenia.

Authors:  J Lauriello; J Bustillo; S J Keith
Journal:  Biol Psychiatry       Date:  1999-11-15       Impact factor: 13.382

Review 5.  Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.

Authors:  S Kapur; G Remington
Journal:  Biol Psychiatry       Date:  2001-12-01       Impact factor: 13.382

6.  Brain volumes in relatives of patients with schizophrenia: a meta-analysis.

Authors:  Heleen B M Boos; André Aleman; Wiepke Cahn; Hilleke Hulshoff Pol; René S Kahn
Journal:  Arch Gen Psychiatry       Date:  2007-03

7.  Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change.

Authors:  Stephen B Soumerai; Fang Zhang; Dennis Ross-Degnan; Daniel E Ball; Robert F LeCates; Michael R Law; Tom E Hughes; Daniel Chapman; Alyce S Adams
Journal:  Health Aff (Millwood)       Date:  2008-04-01       Impact factor: 6.301

Review 8.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

Review 9.  A neurodevelopmental approach to the classification of schizophrenia.

Authors:  R M Murray; E O'Callaghan; D J Castle; S W Lewis
Journal:  Schizophr Bull       Date:  1992       Impact factor: 9.306

10.  The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.

Authors:  Troy A Moore; Robert W Buchanan; Peter F Buckley; John A Chiles; Robert R Conley; M Lynn Crismon; Susan M Essock; Molly Finnerty; Stephen R Marder; Del D Miller; Joseph P McEvoy; Delbert G Robinson; Nina R Schooler; Steven P Shon; T Scott Stroup; Alexander L Miller
Journal:  J Clin Psychiatry       Date:  2007-11       Impact factor: 4.384

View more
  1 in total

1.  Cardiometabolic outcomes among schizophrenia patients using antipsychotics: the impact of high weight gain risk vs low weight gain risk treatment.

Authors:  Rezaul Khandker; Farid Chekani; Brendan Limone; Ellen Thiel
Journal:  BMC Psychiatry       Date:  2022-02-19       Impact factor: 3.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.